Whiting PJ[au] - Search Results

Year	Number of Results
1983	1
1985	1
1986	4
1987	5
1988	3
1991	1
1992	2
1993	7
1994	12
1995	13
1996	10
1997	6
1998	4
1999	10
2000	1
2001	6
2002	9
2003	7
2004	4
2005	6
2006	5
2007	2
2011	1
2015	1
2016	3
2017	2
2018	1
2019	2
2020	1
2022	0

1

Dysregulated Wnt Signalling in the Alzheimer's Brain.

Aghaizu ND, Jin H, Whiting PJ. Aghaizu ND, et al. Among authors: whiting pj. Brain Sci. 2020 Nov 24;10(12):902. doi: 10.3390/brainsci10120902. Brain Sci. 2020. PMID: 33255414 Free PMC article. Review.

2

GABA-A receptors: a viable target for novel anxiolytics?

Whiting PJ. Whiting PJ. Curr Opin Pharmacol. 2006 Feb;6(1):24-9. doi: 10.1016/j.coph.2005.08.005. Epub 2005 Dec 15. Curr Opin Pharmacol. 2006. PMID: 16359919 Review.

3

Which GABAA-receptor subtypes really occur in the brain?

McKernan RM, Whiting PJ. McKernan RM, et al. Among authors: whiting pj. Trends Neurosci. 1996 Apr;19(4):139-43. doi: 10.1016/s0166-2236(96)80023-3. Trends Neurosci. 1996. PMID: 8658597 Review.

4

Structure and pharmacology of vertebrate GABAA receptor subtypes.

Whiting PJ, McKernan RM, Wafford KA. Whiting PJ, et al. Int Rev Neurobiol. 1995;38:95-138. doi: 10.1016/s0074-7742(08)60525-5. Int Rev Neurobiol. 1995. PMID: 8537206 Review. No abstract available.

5

Molecular and functional variation in iPSC-derived sensory neurons.

Schwartzentruber J, Foskolou S, Kilpinen H, Rodrigues J, Alasoo K, Knights AJ, Patel M, Goncalves A, Ferreira R, Benn CL, Wilbrey A, Bictash M, Impey E, Cao L, Lainez S, Loucif AJ, Whiting PJ; HIPSCI Consortium, Gutteridge A, Gaffney DJ. Schwartzentruber J, et al. Among authors: whiting pj. Nat Genet. 2018 Jan;50(1):54-61. doi: 10.1038/s41588-017-0005-8. Epub 2017 Dec 11. Nat Genet. 2018. PMID: 29229984 Free PMC article.

6

gamma-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions.

Boehm SL 2nd, Ponomarev I, Jennings AW, Whiting PJ, Rosahl TW, Garrett EM, Blednov YA, Harris RA. Boehm SL 2nd, et al. Among authors: whiting pj. Biochem Pharmacol. 2004 Oct 15;68(8):1581-602. doi: 10.1016/j.bcp.2004.07.023. Biochem Pharmacol. 2004. PMID: 15451402 Review.

7

The GABA-A receptor gene family: new targets for therapeutic intervention.

Whiting PJ. Whiting PJ. Neurochem Int. 1999 May;34(5):387-90. doi: 10.1016/s0197-0186(99)00048-0. Neurochem Int. 1999. PMID: 10397366 Review.

8

GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?

Whiting PJ. Whiting PJ. Drug Discov Today. 2003 May 15;8(10):445-50. doi: 10.1016/s1359-6446(03)02703-x. Drug Discov Today. 2003. PMID: 12801796 Review.

9

Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.

Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, Katan M, Bilsland J, Lashley T, Chakrabarty P, Golde TE, Whiting PJ. Magno L, et al. Among authors: whiting pj. Alzheimers Res Ther. 2019 Feb 2;11(1):16. doi: 10.1186/s13195-019-0469-0. Alzheimers Res Ther. 2019. PMID: 30711010 Free PMC article.

10

gamma-Aminobutyric acid-A (GABA-A) receptor/ion channel complex.

Ragan CI, McKernan RM, Wafford K, Whiting PJ. Ragan CI, et al. Among authors: whiting pj. Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):622-6. doi: 10.1042/bst0210622. Biochem Soc Trans. 1993. PMID: 7693526 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results